Adherence to Long-Term Therapies: Evidence for Action

This report provides a critical review of what is known about adherence to long-term therapies.This is achieved by looking beyond individual diseases. A broad range of policy options emerges by including communicable diseases such as tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), mental and neurological conditions such as depression and epilepsy, substance dependence (exemplified by smoking cessation), hypertension, asthma and palliative care for cancer.